Pia Lundman

Publications
Grants
CV
Public outreach and news

Articles

Journal article: INTERNATIONAL JOURNAL OF CARDIOLOGY: HEART & VASCULATURE. 2025;56:101570
Enhanced levels of IL-6 and PAI-1 and decreased levels of MMP-3 in cytomegalovirus seropositive patients with prior myocardial infarction
Xu X; Silveira A; Lundman P; Rahbar A; Soderberg-Naucler C
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (EJPC). 2024;31(15):1890-1897
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individuals
Yari A; Ueda P; Lundman P; Alfredsson J; Ravn-Fischer A; Soderberg S; Yndigegn T; Hagstrom E; Jernberg T
Article: CYTOKINE. 2024;182:156696
Inflammatory biomarkers and long-term outcome in young patients three months after a first myocardial infarction
Cederstrom S; Jernberg T; Samnegard A; Johansson F; Silveira A; Tornvall P; Lundman P
Journal article: CARDIOVASCULAR DIABETOLOGY. 2024;23(1):290
Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease
Ritsinger V; Avander K; Lagerqvist B; Lundman P; Norhammar A
Article: CKJ: CLINICAL KIDNEY JOURNAL. 2024;17(3):sfae050
Associations between inflammatory and angiogenic proteomic biomarkers, and cardiovascular events and mortality in relation to kidney function
Salzinger B; Lundwall K; Evans M; Moertberg J; Wallen H; Jernberg T; Kahan T; Lundman P; Tornvall P; Erlinge D; Lindahl B; Baron T; Rezeli M; Spaak J; Jacobson SH
Journal article: EUROPEAN HEART JOURNAL. 2023;44:ehad655.1232
Real-life use of novel glucose lowering agents after acute myocardial infarction and stable coronary artery disease in patients with diabetes - experience from national use in the SWEDEHEART-registry
Ritsinger V; Avander K; Lagerqvist B; Lundman P; Norhammar A
Journal article: EUROPEAN HEART JOURNAL. 2023;44:ehad655.1421
Inflammatory biomarkers and long-term outcome in young stable patients 3 months after a first myocardial infarction
Cederstrom S; Johansson F; Samnegard A; Silveira A; Tornvall P; Jernberg T; Lundman P
Article: JOURNAL OF DIABETES AND ITS COMPLICATIONS. 2023;37(10):108599
Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial
Ritsinger V; Hagstrom E; Hambraeus K; James S; Jernberg T; Lagerqvist B; Leosdottir M; Lundman P; Pernow J; Ostlund O; Norhammar A
Article: SCIENTIFIC REPORTS. 2023;13(1):12171
Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population
Cederstrom S; Lundman P; Alfredsson J; Hagstrom E; Ravn-Fischer A; Soderberg S; Yndigegn T; Tornvall P; Jernberg T
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023;81(6):400-410
Statin Treatment Intensity, Discontinuation, and Long-Term Outcome in Patients With Acute Myocardial Infarction and Impaired Kidney Function
Khedri M; Szummer K; Lundman P; Jernberg T; Desta L; Lindahl B; Erlinge D; Jacobson SH; Spaak J
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2023;373:64-71
Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function
Mortberg J; Salzinger B; Lundwall K; Edfors R; Jacobson SH; Wallen HN; Jernberg T; Baron T; Erlinge D; Andell P; James S; Eggers KM; Hjort M; Kahan T; Lundman P; Tornvall P; Rezeli M; Marko-Varga G; Lindahl B; Spaak J
Journal article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2022;33(11S):530
Impact of Kidney Function on the Association Between Selected Proteomic Biomarkers and Cardiovascular Events and Mortality
Salzinger B; Lundwall K; Evans M; Mortberg JL; Wallen H; Jernberg T; Kahan T; Lundman P; Lindahl B; Spaak J; Jacobson SH
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (EJPC). 2022;29(13):1759-1769
Prognostic impact of type 1 and type 2 diabetes mellitus in atrial fibrillation and the effect of severe hypoglycaemia: a nationwide cohort study
Karayiannides S; Norhammar A; Landstedt-Hallin L; Friberg L; Lundman P
Article: CARDIOVASCULAR DIABETOLOGY. 2021;20(1):227
Impaired fasting glucose: a risk factor for atrial fibrillation and heart failure
Lind V; Hammar N; Lundman P; Friberg L; Talback M; Walldius G; Norhammar A
Article: JOURNAL OF INTERNAL MEDICINE. 2021;290(5):1061-1070
Arginase 1 is upregulated at admission in patients with ST-elevation myocardial infarction
Tengbom J; Cederstrom S; Verouhis D; Bohm F; Eriksson P; Folkersen L; Gabrielsen A; Jernberg T; Lundman P; Persson J; Saleh N; Settergren M; Sorensson P; Tratsiakovich Y; Tornvall P; Jung C; Pernow J
Article: CARDIOVASCULAR DIABETOLOGY. 2021;20(1):122
Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c
Karayiannides S; Djupsjo C; Kuhl J; Hofman-Bang C; Norhammar A; Holzmann MJ; Lundman P
Article: EUROPEAN HEART JOURNAL (EHJ) - CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(2):104-111
Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction
Trevisan M; Fu EL; Szummer K; Norhammar A; Lundman P; Wanner C; Sjoelander A; Jernberg T; Carrero JJ
Article: EUROPEAN HEART JOURNAL - QUALITY OF CARE AND CLINICAL OUTCOMES. 2021;7(1):59-67
Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013-17
Allahyari A; Jernberg T; Lautsch D; Lundman P; Hagstrom E; Schubert J; Boggs R; Salomonsson S; Ueda P
Article: JOURNAL OF INTERNAL MEDICINE. 2020;288(5):581-592
Use of proteomics to identify biomarkers associated with chronic kidney disease and long-term outcomes in patients with myocardial infarction
Edfors R; Lindhagen L; Spaak J; Evans M; Andell P; Baron T; Mortberg J; Rezeli M; Salzinger B; Lundman P; Szummer K; Tornvall P; Wallen HN; Jacobson SH; Kahan T; Marko-Varga G; Erlinge D; James S; Lindahl B; Jernberg T
Article: DIABETES AND VASCULAR DISEASE RESEARCH. 2020;17(6):1479164120973676
Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry
Ritsinger V; Lagerqvist B; Lundman P; Hagstrom E; Norhammar A
Article: EUROPEAN HEART JOURNAL. 2020;41(40):3900-3909
Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study
Allahyari A; Jernberg T; Hagstrom E; Leosdottir M; Lundman P; Ueda P
Article: OPEN HEART. 2020;7(1):e001217
Preoperative disturbances of glucose metabolism and mortality after coronary artery bypass grafting
Djupsjo C; Sartipy U; Ivert T; Karayiannides S; Lundman P; Nystrom T; Holzmann MJ; Kuhl J
Article: JOURNAL OF INTERNAL MEDICINE. 2020;287(1):66-77
New candidate genes for ST-elevation myocardial infarction
Cederstrom S; Lundman P; Folkersen L; Paulsson-Berne G; Karadimou G; Eriksson P; Caidahl K; Gabrielsen A; Jernberg T; Persson J; Tornvall P
Journal article: EUROPEAN HEART JOURNAL. 2019;40(Supplement_1):ehz747.0056
209Glucose is associated with future atrial fibrillation and heart failure already at prediabetes levels, a 19 year follow up of 243,665 subjects
Lind V; Hammar N; Lundman P; Friberg L; Tallback M; Walldius G; Norhammar A
Journal article: EUROPEAN HEART JOURNAL. 2019;40(Supplement_1):ehz746.1187
P6599Upregulation of protein and gene expression of arginase-1 in patients with ST elevation myocardial infarction
Tengbom J; Cederstrom S; Verouhis D; Sorensson P; Bohm F; Saleh N; Jernberg T; Lundman P; Eriksson P; Gabrielsen A; Caidahl K; Persson J; Folkersen L; Tornvall P; Pernow J
Journal article: EUROPEAN HEART JOURNAL. 2019;40(Supplement_1):ehz747.0427
P828Low-density lipoprotein cholesterol lowering therapy and target level attainment after a recent myocardial infarction - nationwide cohort study
Allahyari A; Jernberg T; Lautsch D; Lundman P; Hagstrom E; Schubert J; Boggs R; Salomonsson S; Ueda P
Article: CLINICAL BIOCHEMISTRY. 2019;64:24-29
Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis
Palmer MK; Barter PJ; Lundman P; Nicholls SJ; Toth PP; Karlson BW
Article: JOURNAL OF INTERNAL MEDICINE. 2018;284(6):674-684
Genetic testing for familial hypercholesterolemia among survivors of acute coronary syndrome
Benedek P; Eriksson M; Duvefelt K; Freyschuss A; Frick M; Lundman P; Nylund L; Szummer K
Journal article: EUROPEAN HEART JOURNAL. 2018;39(suppl_1):ehy563.p3674
P3674New candidate genes for plaque rupture in myocardial infarction
Cederstrom S; Lundman P; Folkersen L; Paulsson-Berne G; Eriksson P; Caidahl K; Gabrielsen A; Jernberg T; Persson J; Tornvall P
Article: INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2018;40(3):251-257
VIIaAT complexes, procoagulant phospholipids, and thrombin generation during postprandial lipemia
Silveira A; Carlo A; Adam M; McLeod O; Lundman P; Boquist S; Woodhams BJ; Hamsten A
Article: CARDIOLOGY. 2018;140(1):30-34
Modeling Statin-Induced Reductions of Cardiovascular Events in Primary Prevention: A VOYAGER Meta-Analysis
Karlson BW; Nicholls SJ; Lundman P; Barter PJ; Palmer MK
Article: DIABETES AND VASCULAR DISEASE RESEARCH. 2018;15(1):31-38
High overall cardiovascular risk and mortality in patients with atrial fibrillation and diabetes: A nationwide report
Karayiannides S; Lundman P; Friberg L; Norhammar A
Article: ATHEROSCLEROSIS. 2017;265:54-59
Effects of age, gender and statin dose on lipid levels: Results from the VOYAGER meta-analysis database
Karlson BW; Palmer MK; Nicholls SJ; Barter PJ; Lundman P
Journal article: EUROPEAN HEART JOURNAL. 2017;38(suppl_1):ehx493.p5545
P5545Higher one-year mortality in patients with diabetes mellitus and ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention - a TASTE substudy
Karayiannides S; Norhammar A; Froebert O; James S; Lagerqvist B; Lundman P
Article: EUROPEAN HEART JOURNAL (EHJ) - CARDIOVASCULAR PHARMACOTHERAPY. 2016;2(4):212-217
Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER
Karlson BW; Wiklund O; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Article: DIABETES AND VASCULAR DISEASE RESEARCH. 2016;13(4):307-311
Copeptin, insulin-like growth factor binding protein-1 and sitagliptin: A report from the BEta-cell function in Glucose abnormalities and Acute Myocardial Infarction study
Arnetz L; Hage C; Brismar K; Catrina S-B; Norhammar A; Lundman P; Wallander M; Ryden L; Mellbin L
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2016;117(9):1444-1448
A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia
Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (EJPC). 2016;23(7):744-747
Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysis
Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Article: CARDIOVASCULAR DIABETOLOGY. 2015;14:120
Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia
Kuhl J; Jorneskog G; Wemminger M; Bengtsson M; Lundman P; Kalani M
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2015;4(8):e001853
Sex-Specific Effects of Adiponectin on Carotid Intima-Media Thickness and Incident Cardiovascular Disease
Persson J; Strawbridge RJ; McLeod O; Gertow K; Silveira A; Baldassarre D; Van Zuydam N; Shah S; Fava C; Gustafsson S; Veglia F; Sennblad B; Larsson M; Sabater-Lleal M; Leander K; Gigante B; Tabak A; Kivimaki M; Kauhanen J; Rauramaa R; Smit AJ; Mannarino E; Giral P; Humphries SE; Tremoli E; de Faire U; Lind L; Ingelsson E; Hedblad B; Melander O; Kumari M; Hingorani A; Morris AD; Palmer CNA; Lundman P; Ohrvik J; Soderberg S
Article: ATHEROSCLEROSIS. 2015;241(2):450-454
To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis
Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Article: DIABETES AND VASCULAR DISEASE RESEARCH. 2014;11(4):290-293
The DPP-4 inhibitor sitagliptin and endothelial function in patients with acute coronary syndromes and newly detected glucose perturbations: A report from the BEGAMI study
Hage C; Brismar K; Lundman P; Norhammar A; Ryden L; Mellbin L
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (EJPC). 2013;20(6):1080-1087
Achievement of LDL-C goals depends on baseline LDL-C and choice and dose of statin: An analysis from the VOYAGER database
Palmer MK; Nicholls SJ; Lundman P; Barter PJ; Karlson BW
Article: CLINICAL SCIENCE. 2013;125(7-8):401-407
CARD8 gene encoding a protein of innate immunity is expressed in human atherosclerosis and associated with markers of inflammation
Paramel GV; Folkersen L; Strawbridge RJ; Elmabsout AA; Sarndahl E; Lundman P; Jansson J-H; Hansson GK; Sirsjo A; Fransen K
Journal article: EUROPEAN HEART JOURNAL. 2013;34(suppl_1):p4289
The DPP-4 inhibitor sitagliptin and endothelial function in patients with acute coronary syndromes and newly detected glucose perturbations
Hage C; Brismar K; Lundman P; Mellbin L; Ryden L
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (EJPC). 2013;20(4):549-554
Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes
Hage C; Lundman P; Ryden L; Mellbin L
Article: ATHEROSCLEROSIS. 2013;228(1):265-269
Achievement of 2011 European low-density lipoprotein cholesterol (LDL-C) goals of either <70 mg/dl or ≥50% reduction in high-risk patients: Results from VOYAGER
Karlson BW; Nicholls SJ; Lundman P; Palmer MK; Barter PJ
Article: JOURNAL OF INTERNAL MEDICINE. 2013;273(4):410-421
Sitagliptin improves beta-cell function in patients with acute coronary syndromes and newly diagnosed glucose abnormalities-the BEGAMI study
Hage C; Brismar K; Efendic S; Lundman P; Ryden L; Mellbin L
Article: ATHEROSCLEROSIS. 2012;225(2):491-496
High plasma adiponectin concentration is associated with all-cause mortality in patients with carotid atherosclerosis
Persson J; Folkersen L; Ekstrand J; Helleberg J; Gabrielsen A; Lundman P; Hedin U; Paulsson-Berne G
Article: NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES. 2012;22(9):697-703
Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: Results from VOYAGER
Karlson BW; Barter PJ; Palmer MK; Lundman P; Nicholls SJ
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (EJPC). 2012;19(2):221-230
Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada
Gitt AK; Drexel H; Feely J; Ferrieres J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Juenger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJP
Article: DIABETIC MEDICINE. 2011;28(11):1343-1351
Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study
Leiter LA; Lundman P; da Silva PM; Drexel H; Juenger C; Gitt AK
Article: KIDNEY INTERNATIONAL. 2011;79(9):997-1004
Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction
Szummer K; Lundman P; Jacobson SH; Schon S; Lindback J; Stenestrand U; Wallentin L; Jernberg T
Article: JOURNAL OF INTERFERON AND CYTOKINE RESEARCH. 2011;31(2):259-264
Genetic and Environmental Influences on the Plasma Interleukin-6 Concentration in Patients with a Recent Myocardial Infarction: A Case-Control Study
Bennermo M; Nordin M; Lundman P; Boqvist S; Held C; Samnegard A; Ericsson C-G; Silveira A; Hamsten A; Nastase MM; Tornvall P
Article: JOURNAL OF INTERNAL MEDICINE. 2010;268(2):194-205
Low plasma adiponectin concentration is associated with myocardial infarction in young individuals
Persson J; Lindberg K; Gustafsson TP; Eriksson P; Paulsson-Berne G; Lundman P
Article: JOURNAL OF INTERNAL MEDICINE. 2010;268(1):40-49
Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register
Szummer K; Lundman P; Jacobson SH; Schon S; Lindback J; Stenestrand U; Wallentin L; Jernberg T
Article: AMERICAN HEART JOURNAL. 2010;159(6):979-986
Cockcroft-Gault is better than the Modification of Diet in Renal Disease study formula at predicting outcome after a myocardial infarction: Data from the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)
Szummer K; Lundman P; Jacobson SH; Lindback J; Stenestrand U; Wallentin L; Jernberg T
Article: LAKARTIDNINGEN. 2009;106(50-51):3430-3434
[Chest pain in women with low risk of coronary disease. Think of coronary artery dissection].
Rohman H; Lundman P; Sarkar N; Wallén H
Article: CIRCULATION. 2009;120(10):851-858
Influence of Renal Function on the Effects of Early Revascularization in Non-ST-Elevation Myocardial Infarction Data From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)
Szummer K; Lundman P; Jacobson SH; Schoen S; Lindbaeck J; Stenestrand U; Wallentin L; Jernberg T
Article: ATHEROSCLEROSIS. 2009;204(2):424-428
Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins
Patel S; Puranik R; Nakhla S; Lundman P; Stocker R; Wang XS; Lambert G; Rye K-A; Barter PJ; Nicholls SJ; Celermajer DS
Journal article: ATHEROSCLEROSIS PLUS. 2009;10(2):e417
Abstract: 1068 LOW ADIPONECTIN CONCENTRATION IS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND LEVELS ARE INFLUENCED BY GENETIC VARIANTS
Persson J; Eriksson P; Gustafsson T; Berne GP; Lundman P
Journal article: CANADIAN JOURNAL OF DIABETES. 2009;33(3):242
Characteristics of statin-treated patients with diabetes mellitus in Europe and canada: results of the Dyslipidemia International study
Leiter L; Feely J; Ferrieres J; Gitt A; Gonzalez-Juanatey JR; Thomsen KK; Lundman P; da Silva PM; Pedersen T; Wood D; Kastelein J; Drexel H
Journal article: CIRCULATION. 2008;118(suppl_18)
Abstract 5579: Myocardial Infarction, Clinical Characteristics and Prognosis across Five Renal Function Stages - Data from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions (RIKS-HIA)
Szummer K; Lundman P; Jacobson S; Schön S; Lindbäck J; Stenestrand U; Wallentin L; Jernberg T
Journal article: FUTURE CARDIOLOGY. 2007;3(2):157-164
Impact of statins on atherosclerotic plaque.
Nicholls SJ; Chhatriwalla AK; Lundman P
Article: NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES. 2007;17(3):195-202
A high-fat meat is accompanied by increased plasma interleukin-6 concentrations
Lundman P; Boquist S; Samnegard A; Bennermo M; Held C; Ericsson C-G; Silveira A; Hamsten A; Tornvall P
Journal article: HEART LUNG AND CIRCULATION. 2007;16:s167-s168
Transient Triglyceridaemia Reduces the Anti-inflammatory Properties of High-density Lipoprotein
Patel S; Puranik R; Nakhla S; Lundman P; Rye K; Barter PJ; Nicholls SJ; Celermajer DS
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2006;48(4):715-720
Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function
Nicholls SJ; Lundman P; Harmer JA; Cutri B; Griffiths KA; Rye K-A; Barter PJ; Celermajer DS
Article: JOURNAL OF INTERNAL MEDICINE. 2005;258(5):411-419
Serum matrix metalloproteinase-3 concentration is influenced by MMP-3-1612 5A/6A promoter genotype and associated with myocardial infarction
Samnegård A; Silveira A; Lundman P; Boquist S; Odeberg J; Hulthe J; Mcpheat W; Tornvall P; Bergstrand L; Ericsson CG; Hamsten A; Eriksson P
Journal article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2005;105(1):40-45
Chinese herbs Danshen and Gegen modulate key early atherogenic events in vitro.
Sieveking DP; Woo K-S; Fung KP; Lundman P; Nakhla S; Celermajer DS
Article: JOURNAL OF INTERNAL MEDICINE. 2005;257(5):415-422
Severity of coronary artery stenosis is associated with a polymorphism in the CXCL16/SR-PSOX gene
Lundberg GA; Kellin A; Samnegård A; Lundman P; Tornvall P; Dimmeler S; Zeiher AM; Hamsten A; Hansson GK; Eriksson P
Article: NATURE GENETICS. 2005;37(5):486-494
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction
Swanberg M; Lidman O; Padyukov L; Eriksson P; Åkesson E; Jagodic M; Lobell A; Khademi M; Borjesson O; Lindgren CM; Lundman P; Brookes AJ; Kere J; Luthman H; Alfredsson L; Hillert J; Klareskog L; Hamsten A; Piehl F; Olsson T
Journal article: DIABETIC MEDICINE. 2005;22(3):355-356
New carotid plaque formation is very common in adult patients with Type 2 diabetes mellitus.
Lundman P; Keech AC; Griffiths K; Pillai A; Celermajer DS
Article: THROMBOSIS AND HAEMOSTASIS. 2005;93(3):570-577
Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction
Mannila MN; Eriksson P; Lundman P; Samnegård A; Boquist S; Ericsson CG; Tornvall P; Hamsten A; Silveira A
Article: ATHEROSCLEROSIS. 2005;178(1):193-198
A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein
Kovacs A; Green F; Hansson LO; Lundman P; Samnegård A; Boquist S; Ericsson CG; Watkins HH; Hamsten A; Tornvall P
Article: THROMBOSIS AND HAEMOSTASIS. 2004;92(5):1122-1128
Effect of interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe
Kelberman D; Hawe E; Luong LA; Mohamed-Ali V; Lundman P; Tornvall P; Aillaud MF; Juhan-Vague I; Yudkin JS; Margaglione M; di Minno G; Tremoli E; Humphries SE
Article: METABOLISM: CLINICAL AND EXPERIMENTAL. 2004;53(7):852-857
Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: The HIFMECH study
Yudkin JS; Juhan-Vague I; Hawe E; Humphries SE; di Minno G; Margaglione M; Tremoli E; Kooistra T; Morange PE; Lundman P; Mohamed-Ali V; Hamsten A
Journal article: SEMINARS IN VASCULAR MEDICINE. 2004;4(2):187-195
The emerging role of lipoproteins in atherogenesis: beyond LDL cholesterol.
Nicholls S; Lundman P
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2004;24(3):551-557
Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease
Eriksson P; Deguchi H; Samnegård A; Lundman P; Boquist S; Tornvall P; Ericsson CG; Bergstrand L; Hansson LO; Ye S; Hamsten A
Article: BLOOD COAGULATION AND FIBRINOLYSIS. 2003;14(8):749-753
No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction
Lagercrantz J; Bergman M; Lundman P; Tornvall P; Hjemdahl P; Hamsten A; Eriksson P
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2003;91(9):1128-1131
Relation of hypertriglyceridemia to plasma concentrations of biochemical markers of inflammation and endothelial activation (C-reactive protein, interleukin-6, soluble adhesion molecules, von Willebrand factor, and endothelin-1)
Lundman P; Eriksson MJ; Silveira A; Hansson LO; Pernow J; Ericsson CG; Hamsten A; Tornvall P
Journal article: AMERICAN JOURNAL OF CARDIOLOGY. 2002;90(4):447
Acute triglyceridemia and endothelial function.
Lundman P; Tornvall P
Article: ATHEROSCLEROSIS. 2001;159(1):35-41
A triglyceride-rich fat emulsion and free fatty acids but not very low density lipoproteins impair endothelium-dependent vasorelaxation
Lundman P; Tornvall P; Nilsson L; Pernow J
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2001;38(1):111-116
Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine
Lundman P; Eriksson MJ; Stühlinger M; Cooke JP; Hamsten A; Tornvall P
Article: CORONARY ARTERY DISEASE. 2000;11(7):523-526
Greater than normal prevalence of seropositivity for Helicobacter pylori among patients who have suffered myocardial infarction
Kahan T; Lundman P; Olsson G; Wendt M
Article: CIRCULATION. 2000;101(3):227-230
Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease
Björkegren J; Boquist S; Samnegård A; Lundman P; Tornvall P; Ericsson CG; Hamsten A
Article: CIRCULATION. 1997;96(10):3266-3268
Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease
Lundman P; Eriksson M; SchenckGustafsson K; Karpe F; Tornvall P
Article: INTERNATIONAL IMMUNOLOGY. 1995;7(4):625-633
A CD4(+) T-CELL LINE-SECRETED FACTOR, GROWTH-PROMOTING FOR NORMAL AND LEUKEMIC A CELLS, IDENTIFIED AS THIOREDOXIN
ROSEN A; LUNDMAN P; CARLSSON M; BHAVANI K; SRINIVASA BR; KJELLSTROM G; NILSSON K; HOLMGREN A
Show more

All other publications

Conference publication: DIABETOLOGIA. 2023;66(SUPPL 1):S131
Real-life use of novel glucose lowering agents in coronary artery disease: experience from the SWEDHEART-registry
Ritsinger V; Avander K; Lagerqvist B; Lundman P; Norhammar A
Conference publication: EUROPEAN HEART JOURNAL. 2022;43:1157
Association between high sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population
Cederstrom S; Lundman P; Alfredsson J; Hagstrom E; Ravn-Fischer A; Soderberg S; Yndigegn T; Tornvall P; Jernberg T
Conference publication: EUROPEAN HEART JOURNAL. 2022;43:2279
Distribution of cardiovascular disease risk according to SCORE2 and potential need for cholesterol and blood pressure lowering therapy in apparently healthy middle-aged individuals
Yari A; Ueda P; Hagstrom E; Lundman P; Ravn-Fischer A; Soderberg S; Yndigegn T; Jernberg T
Conference publication: DIABETOLOGIA. 2022;65(SUPPL 1):S433-S434
Prognosis in men and women with atrial fibrillation without and with type 1 and type 2 diabetes: a nationwide propensity-matched cohort study
Karayiannides S; Lundman P; Landstedt-Hallin L; Friberg L; Norhammar A
Corrigendum: CLINICAL BIOCHEMISTRY. 2020;76:49
Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis (vol 64, pg 24, 2019)
Palmer MK; Barter PJ; Lundman P; Nicholls SJ; Toth PP; Karlson BW
Conference publication: DIABETOLOGIA. 2020;63(SUPPL 1):S81-S82
Prognosis in patients with atrial fibrillation and type 1 diabetes, type 2 diabetes and severe hypoglycaemia: a nationwide report
Karayiannides S; Norhammar A; Landstedt-Hallin L; Friberg L; Lundman P
Conference publication: CIRCULATION. 2019;140
Preoperative Disturbances of Glucose Metabolism and Mortality After Coronary Artery Bypass Grafting
Djupsjo C; Sartipy U; Ivert T; Karayiannides S; Lundman P; Nystrom T; Holzmann MJ; Kuhl J
Conference publication: EUROPEAN HEART JOURNAL. 2019;40:58
Glucose is associated with future atrial fibrillation and heart failure already at prediabetes levels, a 19 year follow up of 243,665 subjects
Lind V; Hammar N; Lundman P; Friberg L; Tallback M; Walldius G; Norhammar A
Conference publication: EUROPEAN HEART JOURNAL. 2019;40:4193
Upregulation of protein and gene expression of arginase-1 in patients with ST elevation myocardial infarction
Tengbom J; Cederstrom S; Verouhis D; Sorensson P; Bohm F; Saleh N; Jernberg T; Lundman P; Eriksson P; Gabrielsen A; Caidahl K; Persson J; Folkersen L; Tornvall P; Pernow J
Conference publication: EUROPEAN HEART JOURNAL. 2019;40:429
Low-density lipoprotein cholesterol lowering therapy and target level attainment after a recent myocardial infarction - nationwide cohort study
Allahyari A; Jernberg T; Lautsch D; Lundman P; Hagstrom E; Schubert J; Boggs R; Salomonsson S; Ueda P
Conference publication: DIABETOLOGIA. 2019;62:S152-S153
Preoperative disturbances of glucose metabolism and mortality after coronary artery bypass grafting
Djupsjo C; Sartipy U; Ivert T; Karayiannides S; Lundman P; Nystrom T; Holzmann M; Kuhl J
Letter: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2018;72(12):1427-1428
Prognosis in Patients With Diabetes Mellitus and STEMI Undergoing Primary PCI
Karayiannides S; Norhammar A; Frobert O; James SK; Lagerqvist B; Lundman P
Conference publication: EUROPEAN HEART JOURNAL. 2018;39:766-767
New candidate genes for plaque rupture in myocardial infarction
Cederstrom S; Lundman P; Folkersen L; Paulsson-Berne G; Eriksson P; Caidahl K; Gabrielsen A; Jernberg T; Persson J; Tornvall P
Conference publication: DIABETOLOGIA. 2017;60:S534-S535
Prognostic differences in men and women with atrial fibrillation and diabetes: a nationwide report
Karayiannides S; Lundman P; Friberg L; Norhammar A
Conference publication: DIABETOLOGIA. 2017;60:S529-S530
Higher one-year mortality in patients with diabetes and ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Lundman P; Karayiannides S; Froebert O; James S; Lagerqvist B; Norhammar A
Conference publication: EUROPEAN HEART JOURNAL. 2017;38:1188
Higher one-year mortality in patients with diabetes mellitus and ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention - a TASTE substudy
Karayiannides S; Norhammar A; Froebert O; James S; Lagerqvist B; Lundman P
Conference publication: DIABETOLOGIA. 2016;59:S551
High overall cardiovascular risk and mortality in patients with atrial fibrillation suffering from diabetes: a nationwide report
Karayiannides S; Lundman P; Fiberg L; Norhammar A
Conference publication: ATHEROSCLEROSIS. 2015;241(1):E202-E203
PREDICTING THE REDUCTION IN RISK OF CARDIOVASCULAR EVENTS WITH HIGH-INTENSITY STATIN TREATMENT: A VOYAGER ANALYSIS
Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: ATHEROSCLEROSIS. 2015;241(1):E21-E22
ESTIMATING THE REDUCTION IN 10-YEAR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK WITH STATIN THERAPY: A VOYAGER META-ANALYSIS
Palmer M; Nicholls SJ; Lundman P; Barter PJ; Karlson BW
Conference publication: EUROPEAN HEART JOURNAL. 2015;36:1151
Estimating the reduction in 10-year atherosclerotic cardiovascular disease risk with statin therapy: a VOYAGER meta-analysis
Palmer MK; Nicholls SJ; Lundman P; Barter PJ; Karlson BW
Conference publication: DIABETOLOGIA. 2015;58:S554-S555
Long-term clinical outcomes in patients with acute coronary syndrome and dysglycaemia
Kuhl J; Jorneskog G; Bengtsson M; Lundman P; Kalani M
Conference publication: CARDIOLOGY. 2015;131:28-29
Reductions in Low-Density Lipoprotein Cholesterol and Triglyceride with Statins in Patients with Hypertriglyceridaemia: Results from VOYAGER
Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: CARDIOLOGY. 2015;131:26-27
Distribution of LDL-C Reduction with Atorvastatin, Rosuvastatin and Simvastatin: A VOYAGER Meta-Analysis
Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: CARDIOLOGY. 2015;131:20
Equipotent Effects of Rosuvastatin, Atorvastatin and Simvastatin on LDL-C Reduction: Results from the Voyager Meta-Analysis
Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: ATHEROSCLEROSIS. 2014;235(2):E295
VARIABILITY OF LDL-C RESPONSE WITH DIFFERENT DOSES OF SIMVASTATIN, ATORVASTATIN AND ROSUVASTATIN: RESULTS FROM VOYAGER
Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: ATHEROSCLEROSIS. 2014;235(2):E11-E12
ATTAINMENT OF THE ANTICIPATED >=50% REDUCTION IN LDL-C IN THE FOUR ACC/AHA GUIDELINES STATIN BENEFIT GROUPS: A VOYAGER META-ANALYSIS
Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: ATHEROSCLEROSIS. 2014;235(2):E35
DOSES OF ROSUVASTATIN, ATORVASTATIN AND SIMVASTATIN INDUCING AN EQUIPOTENT EFFECT ON LDL-C: RESULTS FROM THE VOYAGER META-ANALYSIS
Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: EUROPEAN HEART JOURNAL. 2014;35:679
To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in the four statin benefit groups identified by the ACC/AHA 2013 guidelines? A VOYAGER meta-analysis
Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: EUROPEAN HEART JOURNAL. 2014;35:217
Impact of statin therapy on low-density lipoprotein cholesterol and triglyceride levels in patients with hypertriglyceridaemia: a VOYAGER meta-analysis
Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: EUROPEAN HEART JOURNAL. 2013;34:793
The DPP-4 inhibitor sitagliptin and endothelial function in patients with acute coronary syndromes and newly detected glucose perturbations
Hage C; Brismar K; Lundman P; Mellbin L; Ryden L
Conference publication: EUROPEAN HEART JOURNAL. 2012;33:883-884
The DPP-IV inhibitor sitagliptin improves beta-cell function in patients with acute coronary syndromes and newly diagnosed glucose abnormalities
Hage C; Brismar KB; Efendic SE; Lundman PL; Ryden LR; Mellbin LGM
Conference publication: ATHEROSCLEROSIS SUPPLEMENTS. 2011;12(1):164
EFFECT OF ROSUVASTATIN AND ATORVASTATIN DOSE ON LDL-C <70MG/DL GOAL ATTAINMENT IN PATIENTS WITH DIABETES MELLITUS: RESULTS FROM VOYAGER
Karlson BW; Barter PJ; Palmer MK; Lundman P; Nicholls SJ
Conference publication: ATHEROSCLEROSIS SUPPLEMENTS. 2011;12(1):164
FAVOURABLE IMPACT ON LIPID LEVELS OF INCREASING STATIN DOSE IN HIGH-RISK PATIENTS WITH VERY HIGH BASELINE LDL-C: RESULTS FROM VOYAGER
Lundman P; Palmer MK; Karlson BW; Barter PJ; Nicholls SJ
Corrigendum: JOURNAL OF INTERNAL MEDICINE. 2011;269(4):468
Low plasma adiponectin concentration is associated with myocardial infarction in young individuals (vol 268, pg 194, 2010)
Persson J; Lindberg K; Gustafsson TP; Eriksson P; Paulsson-Berne G; Lundman P
Conference publication: EUROPEAN HEART JOURNAL. 2011;32:227
Impact of diabetes on LDL-cholesterol target achievement in patients with cardiovascular disease in clinical practice in Europe and Canada: results of the dyslipidemia international study
Gitt AK; Leiter L; Lundman P; Drexel H; Ferrieres J; Gonzalez-Juanatey JR; Pedersen T; Thomsen KK; Wood D; Kastelein JP
Conference publication: EUROPEAN HEART JOURNAL. 2011;32:342
Baseline LDL-C and choice and dose of statin as determinants of LDL-C goal achievement: meta-analysis from the VOYAGER database
Karlson BW; Nicholls SJ; Lundman P; Barter PJ; Palmer MK
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2010;11(2):119-120
EFFECTS OF AGE AND STATIN DOSE ON LIPID LEVELS: RESULTS FROM THE VOYAGER INDIVIDUAL PATIENT DATA META-ANALYSIS
Nicholls SJ; Lundman P; Brandrup-Wognsen G; Palmer M; Barter PJ
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2010;11(2):75
DOES GENDER IMPACT ON STATIN DOSE RESPONSE? RESULTS FROM THE VOYAGER INDIVIDUAL PATIENT DATA META-ANALYSIS
Lundman P; Nicholls SJ; Brandrup-Wognsen G; Palmer M; Barter PJ
Review: JOURNAL OF CARDIOVASCULAR RISK. 2010;17 Suppl 1:S20-S24
Diabetic dyslipidemia: extending the target beyond LDL cholesterol.
Nicholls SJ; Lundman P; Tardif J-C
Conference publication: EUROPEAN HEART JOURNAL. 2010;31:391
Impact of increasing statin dose on the ratio of atherogenic to protective lipid parameters: insights from the VOYAGER individual patient data meta-analysis
Nicholls SJ; Lundman P; Brandrup-Wognsen G; Palmer MK; Barter PJ
Conference publication: EUROPEAN HEART JOURNAL. 2010;31:373
Predictors of LDL-cholesterol goal achievement in secondary prevention in Europe and Canada: results of the Dyslipidemia International Study
Gitt AK; Juenger C; Smolka W; Bestehorn K; Lundman P; Leiter L; Pedersen T; Gonzalez-Juanatey J; Chazelle F; Kastelein J
Conference publication: EUROPEAN HEART JOURNAL. 2010;31:373
Germany lags behind other European Countries and Canada in LDL-cholesterol goal achievement according to existing guidelines: results of the Dyslipidemia International Study
Gitt AK; Juenger C; Smolka W; Bestehorn K; Leiter L; Lundman P; Gonzalez-Juanatey J; Pedersen T; Chazelle F; Kastelein J
Conference publication: EUROPEAN HEART JOURNAL. 2010;31:604-605
The strong association between renal function and mortality is not influenced by chosen reperfusion strategy - data from the SWEDEHEART registry
Szummer K; Lundman P; Jacobson SH; Schon S; Lindback J; Wallentin L; Jernberg T
Conference publication: EUROPEAN HEART JOURNAL. 2009;30:514-515
Prevalence of lipid disorders in statin treated patients from Sweden, Norway and Denmark: Results from the Dyslipidemia International Study (DYSIS)
Thomsen KK; Lundman P; Salling S; Journath G; Pedersen T
Conference publication: DIABETOLOGIA. 2009;52:S131
High prevalence of residual dyslipidemia in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidemia International Study
Drexel H; Feely J; Ferrieres J; Gitt A; Gonzalez-Juanatey J-R; Thomsen KK; Lundman P; da Silva PM; Pedersen T; Wood D; Chazelle F; Hackett M; Kastelein J; Leiter L
Conference publication: ATHEROSCLEROSIS SUPPLEMENTS. 2009;10(2)
LOW ADIPONECTIN CONCENTRATION IS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND LEVELS ARE INFLUENCED BY GENETIC VARIANTS
Persson J; Eriksson P; Gustafsson T; Berne GP; Lundman P
Conference publication: CARDIOLOGY. 2009;113:116
Prevalence of lipid disorders in statin treated patients from Sweden, Norway and Denmark: results from the Dyslipidemia International Study (DYSIS)
Thomsen KK; Salling S; Lundman P; Journath G; Pedersen T
Conference publication: CIRCULATION. 2009;120(18):S501
Statin Use After Myocardial linfarction Improves Survival in Nearly All With Renal Dysfunction: Data From the Swedish Web-system for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)
Szummer K; Lundman P; Jacobson S; Schon S; Lindback J; Stenestrand U; Wallentin L; Jernberg T
Conference publication: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2009;53(10):A354
Cockcroft-Gault Is Better Than the Modi. cation of Diet in Renal Disease Study Formula to Predict Outcome Following a Myocardial Infarction-Data From Swedish Register of Information and Knowledge
Szummer K; Jacobson SH; Lundman P; Lindback J; Stenestrand U; Wallentin L; Jernberg T
Conference publication: CIRCULATION. 2008;118(18):S969
Early Invasive Therapy in Non-ST-elevation Myocardial Infarction Improves Survival Although Benefit Declines with Worsening Renal Function - Data from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA)
Szummer K; Lundman P; Jacobson S; Schon S; Lindback J; Stenestrand U; Wallentin L; Jemberg T
Conference publication: CIRCULATION. 2008;118(18):S966-S967
Myocardial Infarction, Clinical Characteristics and Prognosis across Five Renal Function Stages - Data from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions (RIKS-HIA)
Szummer K; Lundman P; Jacobson S; Schon S; Lindback J; Stenestrand U; Wallentin L; Jernberg T
Conference publication: CIRCULATION. 2005;112(17):U435-U436
Consumption of saturated fat impairs endothelial function and the anti-inflammatory properties of high density lipoproteins
Nicholls SJ; Lundman P; Harmer J; Cutri B; Griffiths K; Rye KA; Barter PJ; Celermajer DS
Conference publication: CIRCULATION. 2005;112(17):U43
Consumption of saturated fat impairs endothelial function and the antiinflammatory properties of high-density lipoproteins
Nicholls SJ; Lundman P; Harmer J; Cutri B; Griffiths K; Rye KA; Barter PJ; Celermajer DS
Letter: CARDIOLOGY. 2003;99(4):214-215
A case report supporting multiple plaque ruptures in CAD
Tornvall P; Jensen J; Persson H; Lundman P
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2003;4(2):323
Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease
Eriksson P; Deguchi H; Samnegard A; Lundman P; Boquist S; Tornvall P; Ericsson CG; Bergstrand L; Hansson LO; Hamsten A
Thesis / dissertation: 2001
Effects of triglycerides on the endothelium
Lundman, Pia
Conference publication: CIRCULATION. 2001;104(17):240
Mild to moderate hypertriglyceridemia is associated with endothelial dysfunction and low-grade inflammation
Lundman PIM; Eriksson MJ; Stuehlinger M; Cooke JP; Tornvall P
Letter: CIRCULATION. 1998;98(17):1827
Triglycerides and postprandial angina - Response
Lundman P; Tornvall P; Eriksson M; Schenck-Gustafsson K; Karpe F
Show more

Grants

The Myocardial Infarction and new treatment with Metformin study (MIMET) - a registry based randomised controlled trial
Swedish Research Council
1 January 2019 - 31 December 2021
Diabetes and cardiovascular disease
Swedish Heart-Lung Foundation
1 January 2019 - 31 December 2019

Employments

Senior Lecturer/Senior Physician, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 2015-

Degrees and Education

Doctor Of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2001
University Medical Degree, Karolinska Institutet, 1993

Articles

All other publications

Grants

Employments

Degrees and Education

News from KI

Events from KI